Korea United Pharm Inc. (KRX:033270)
South Korea · Delayed Price · Currency is KRW 20,150
+150 (0.75%)
Last updated: Dec 19, 2025, 2:06 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 294.99 billion as of December 19, 2025. Its market cap has increased by 5.54% in one year.
Market Cap
294.99B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
15.90
Stock Price
20,150.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 294.99B, an increase of 762.11%. That is a compound annual growth rate of 9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 294.99B | 10.12% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | 1.03T | 262.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.84T |
| ALTEOGEN | 23.05T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.10T |
| Yuhan | 8.52T |
| LigaChem Biosciences | 6.08T |
| HLB Co., Ltd. | 6.05T |